Cidara Therapeutics Inc. (CDTX)
19.99
-0.93 (-4.45%)
At close: Jan 15, 2025, 11:17 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -22.93M | -29.80M | -42.47M | -72.11M | -41.09M | -59.02M | -55.73M | -48.16M | -32.19M | -11.89M | -1.34M | -792.00K |
| Depreciation & Amortization | 118.00K | 1.23M | -1.23M | 229.00K | 375.00K | 523.00K | 667.00K | 732.00K | 461.00K | 179.00K | n/a | n/a |
| Stock-Based Compensation | 3.06M | 3.53M | 4.01M | 4.09M | 5.07M | 5.71M | 5.71M | 4.34M | 3.03M | 232.00K | 11.00K | n/a |
| Other Working Capital | 3.70M | -584.00K | 8.62M | 24.52M | 8.27M | -340.00K | -1.22M | 1.57M | 563.00K | 1.89M | 23.00K | n/a |
| Other Non-Cash Items | 1.24M | 1K | 15.00K | 21.00K | 36.00K | 86.00K | 50.00K | 14.00K | 76.00K | 1.88M | 262.00K | 792.00K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | -411.00K | -3.61M | -33.00K | -176.00K | -42.00K | n/a | n/a | n/a |
| Change in Working Capital | -3.92M | -3.43M | 14.44M | 13.36M | 7.49M | -399.00K | -579.00K | 3.48M | 2.71M | 1.89M | 23.00K | n/a |
| Operating Cash Flow | -22.43M | -28.47M | -25.23M | -54.41M | -28.53M | -56.70M | -49.91M | -39.77M | -25.96M | -7.71M | -1.05M | n/a |
| Capital Expenditures | -505.00K | -118.00K | -41.00K | -186.00K | -35.00K | -177.00K | -306.00K | -401.00K | -1.17M | -991.00K | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | -14.55M | -19.52M | -69.62M | -54.92M | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | 29.03M | 24.30M | 95.50M | 10.00M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | 14.48M | 4.78M | 25.88M | -44.92M | n/a | n/a | n/a |
| Investing Cash Flow | -505.00K | -118.00K | -41.00K | -186.00K | -35.00K | 14.30M | 4.47M | 25.48M | -46.09M | -991.00K | n/a | n/a |
| Debt Repayment | n/a | -2.59M | -4.44M | -2.96M | n/a | n/a | n/a | 9.95M | n/a | 930.00K | 1.23M | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | -79.00K | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 21.00K | -720.00K | 6.00K | 14.00K | -24.00K | 49.71M | 228.00K | 525.00K | 42.31M | 30.38M | n/a | 12.00K |
| Financial Cash Flow | 25.98M | -951.00K | 44.60M | 37.28M | 14.27M | 56.15M | 20.88M | 37.09M | 111.81M | 31.31M | 1.23M | 12.00K |
| Net Cash Flow | 3.05M | -29.54M | 19.32M | -17.32M | -14.29M | 13.75M | -24.55M | 22.80M | 39.77M | 22.61M | 184.00K | 12.00K |
| Free Cash Flow | -22.94M | -28.59M | -25.27M | -54.60M | -28.57M | -56.88M | -50.22M | -40.17M | -27.13M | -8.70M | -1.05M | n/a |